Vijaya Diagnostic Centre IPO Details
Vijaya Diagnostic IPO description – Vijaya Diagnostic Centre is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chain by revenue for FY2020. Its network includes 80 diagnostic centre and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata. During FY2021, the company derived 96.2% of its revenue from operations from its core geographies, Hyderabad and rest of Telangana and Andhra Pradesh.
The company offers a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines, as of 31 March 2021. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerised tomography (“CT”) scans, magnetic resonance imaging (“MRI”) scans, single photon emission computed tomography (“SPECT”) and advanced positron emission tomography CT (“PET CT”).
Vijaya Diagnostic Centre has implemented a ‘hub and spoke’ model, whereby specimens are collected across multiple locations within a catchment area or a region for delivery to its reference laboratories for diagnostic testing. This model provides greater economies of scale and enhances consistency of its testing procedures and results. As of 31 March 2021, iits operational network consists of diagnostic centre network of (i) a flagship centre located in Hyderabad, which is its main ‘hub’ and equipped to conduct all of pathology specimens collection, basic and advanced radiology tests; (ii) 19 hub centres, which are equipped to conduct all of pathology specimens collection, basic radiology tests and certain advanced radiology tests; and (iii) 60 diagnostic centres, which are equipped to conduct a majority of pathology specimen collection and certain basic radiology tests. Its laboratory network includes (i) a national reference laboratory co-located with its flagship centre; and (ii) 10 reference laboratories co-located with certain hub centres and diagnostic centres.
Promoters of Vijaya Diagnostic Centre – Dr S Surendranath Reddy
Vijaya Diagnostic Centre IPO details | |
Subscription Dates | 1 – 3 September 2021 |
Price Band | INR522 – 531 per share |
Fresh issue | Nil |
Offer For Sale | 35,688,064 shares (INR1,862.92 – 1,895.04 crore) |
Total IPO size | 35,688,064 shares (INR1,862.92 – 1,895.04 crore) |
Minimum bid (lot size) | 28 shares |
Face Value | INR1 per share |
Retail Allocation | 35% |
Listing On | NSE, BSE |
Vijaya Diagnostic Centre Financial Performance (in INR crore)
FY2019 |
FY2020 |
FY2021 |
Q1 FY2022 |
|
Revenue |
302.9 |
354.2 |
388.6 |
126.0 |
Expenses |
237.6 |
270.8 |
276.5 |
81.8 |
Net income |
45.7 |
62.4 |
84.3 |
32.9 |
Margin (%) |
15.1 |
17.6 |
21.7 |
26.1 |
More about Vijaya Diagnostic IPO
Registrar of Vijaya Diagnostic IPO
KFin Technologies Private Limited
Selenium Tower B, Plot 31-32, Gachibowli,
Nanakramguda, Hyderabad – 500 032,
Telangana
Phone: +91 40 6716 2222
Fax: +91 40 2343 1551
Email: [email protected]
Website: www.kfintech.com
Vijaya Diagnostic Centre Contact Details
Vijaya Diagnostic Centre Limited
# 6-3-883/F, Ground Floor of Family Planning Association of India,
Panjagutta, Hyderabad-500 082
Phone: +91 40 2342 0411
Email: [email protected]
Website: www.vijayadiagnostic.com
Valuation of Vijaya Diagnostic Centre (as of FY2021)
Earnings Per Share (EPS): INR8.26
Price/Earnings (PE ratio): 63.20 – 64.29
Return on Net Worth (RONW): 23.64%
Net Asset Value (NAV): INR35.23 per share
Vijaya Diagnostic Centre IPO GMP Daily Trend
Date | Vijaya Diagnostic IPO GMP | Kostak | Subject to Sauda |
13 September 2021 | – | – | – |
11 September 2021 | – | – | – |
9 September 2021 | INR5 | Few trades | Few trades |
8 September 2021 | INR5 | Few trades | Few trades |
7 September 2021 | INR5 | Few trades | Few trades |
6 September 2021 | INR5 | – | – |
4 September 2021 | INR5 | – | – |
3 September 2021 | INR10 | – | – |
2 September 2021 | INR15 | – | INR180 |
1 September 2021 | INR15 | – | INR180 |
31 August 2021 | INR20 | – | INR200 |
30 August 2021 | INR20 | – | INR200 |
28 August 2021 | INR20 | – | INR200 |
27 August 2021 | INR40 | – | – |
26 August 2021 | INR40 | – | – |
Vijaya Diagnostic Centre IPO Subscription Details
Category | Shares offered | Subscription (no. of times, at 5 PM) | ||
Day 1 | Day 2 | Day 3 | ||
QIB | 71,07,613 | 0.23 | 0.32 | 13.07 |
NII | 53,30,710 | 0.01 | 0.05 | 1.32 |
Retail | 1,24,38,323 | 0.46 | 0.74 | 1.09 |
Employees | 1,50,000 | 0.24 | 0.52 | 0.98 |
Total | 2,50,26,646 | 0.30 | 0.47 | 4.54 |
Vijaya Diagnostic IPO Reviews
Angel One –
Anand Rathi –
Antique Stock Broking –
Arihant Capital – Subscribe for listing gains
Ashika Research –
BP Wealth –
Canara Bank Securities –
Choice Broking – Avoid
Elite Wealth – Subscribe
Hem Securities –
ICICIdirect – Unrated
KR Choksey – Subscribe
Marwadi Financial Services – Subscribe
Mehta Equities – Subscribe
Motilal Oswal –
Nirmal Bang – Subscribe for long term
Prabhudas Lilladher –
Reliance Securities – Subscribe
Samco Securities – Avoid
SMC Global – 2/5
Ventura Securities – Subscribe
Vijaya Diagnostic IPO Allotment Status
Vijaya Diagnostic IPO allotment is now available on KFin Technologies’ website. Click on this link to get allotment status.
Listing Performance of Vijaya Diagnostic Centre
IPO Opening Date: 1 September 2021
IPO Closing Date: 3 September 2021
Finalisation of Basis of Allotment: 8 September 2021
Initiation of refunds: 9 September 2021
Transfer of shares to demat accounts: 13 September 2021
Listing Date: 14 September 2021
Opening Price on NSE: INR540 per share (up 1.69% from IPO price)
Closing Price on NSE: INR620.1 per share (up 16.78% from IPO price)